Potassium Carbonate → HCID 69198236, compound

HRID 2224228Notes

Reaction equation

[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[N:12][N:11]3[C:14](=[O:17])[NH:15]N=[C:10]3[C:9]=2[C:18]2[CH:23]=[CH:22][C:21]([Cl:24])=[CH:20][CH:19]=2)=[CH:4][CH:3]=1.[CH2:25]([O:29][CH2:30][CH:31]1[O:33][CH2:32]1)[CH:26]([CH3:28])[CH3:27].[C:34]([O-])([O-])=O.[K+].[K+]>CN(C=O)C>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[CH:13]=[N:12][N:11]3[C:14](=[O:17])[N:15]([CH2:32][CH:31]([OH:33])[CH2:30][O:29][CH2:25][CH:26]([CH3:28])[CH3:27])[CH:34]=[C:10]3[C:9]=2[C:18]2[CH:19]=[CH:20][C:21]([Cl:24])=[CH:22][CH:23]=2)=[CH:6][CH:7]=1

Participants

Conditions

Temperature: 85 °C

Procedure

To a solution of 7,8-bis(4-chlorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one, (20 mg, 0.056 mmol), prepared as described in Example 1, in 0.6 mL of DMF was added glycidyl isobutyl ether (7.3 mg, 0.056 mmol), followed by K2CO3 (15.5 mg, 0.112 mmol). The mixture was heated at 85° C. After stirring overnight, the reaction was allowed to cool to RT The reaction mixture was filtered to remove excess of K2CO3. The collected solution was concentrated under reduced pressure. The crude product was purified using reverse phase HPLC to give the title compound, 3,4-bis(4-chlorophenyl)-6-(2-hydroxy-3-isobutoxypropyl)imidazo[1,5-b]pyridazin-7(6H)-one (17.8 mg, 65% yield) as a yellow solid. in 65% yield. MS [M+H]+: found 487; 1H NMR (CDCl3, 400 MHz) δ 8.08 (s, 1H), 7.23-7.15 (m, 6H), 7.00-6.96 (m, 2H), 4.20-4.00 (m, 3H), 3.41 (d, 2H), 3.11 (d, 2H), 1.80-1.65 (m, 1H), 0.76 (d, 6H).

Workup

temperatureto cool to RT The reaction mixture
filtrationwas filtered
customto remove excess of K2CO3
concentrationThe collected solution was concentrated under reduced pressure
customThe crude product was purified

Sources & evidence

ORD record: ord-00b7bedda4824288ba2fce866f55a0f7
Source dataset: uspto-grants-2008_05
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07378418B2

Reaction notes

Loading…